Status:
ACTIVE_NOT_RECRUITING
Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs
Lead Sponsor:
Kirby Institute
Conditions:
Hepatitis C
Hepatitis C, Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project aims to evaluate two strategies of Hepatitis C virus (HCV) testing compared to standard of care among people who inject drugs at needle and syringe program (NSP) services in Australia, to...
Detailed Description
The TEMPO study will compare dried blood spot testing and point-of-care HCV RNA testing to standard of care as strategies to enhance HCV treatment uptake among people with HCV and recent injecting dru...
Eligibility Criteria
Inclusion
- Inclusion criteria for participants:
- Attendees of the NSP service are eligible for inclusion if the following criteria are met:
- Provided written informed consent
- ≥ 18 years of age
- Recent injecting drug use - defined as self-reported use within the previous six months.
- Exclusion criteria for participants:
- a. Is unable or unwilling to provide informed consent or abide by the requirements of the study.
Exclusion
Key Trial Info
Start Date :
July 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
2700 Patients enrolled
Trial Details
Trial ID
NCT04014179
Start Date
July 27 2022
End Date
July 31 2026
Last Update
July 17 2025
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Bankstown NSP
Bankstown, New South Wales, Australia, 2200
2
WSLHD Drug Health - Blacktown NSP
Blacktown, New South Wales, Australia, 2148
3
Coffs Harbour Primary NSP
Coffs Harbour, New South Wales, Australia, 2450
4
Gosford NSP
Gosford, New South Wales, Australia, 2250